AI-powered remote patient monitoring (RPM) β combining continuous wearable sensor data with machine learning to identify deteriorating patients before clinical crisis β is reducing hospital readmissions by 20β30% and enabling earlier intervention for chronic disease patients who previously had no real-time clinical oversight. FDA-cleared RPM AI systems are now deployed at scale in cardiovascular, diabetes, COPD, and post-surgical monitoring programmes. This guide covers the technology architecture, FDA regulatory pathway, and enterprise deployment approach for health system technology leaders.
RPM Technology Stack
| Layer | Components | Enterprise Examples |
| Wearable sensors | Continuous ECG, SpO2, heart rate, activity, blood pressure, CGM | Apple Watch, AliveCor KardiaMobile, Dexcom G7, Withings ScanWatch |
| IoT connectivity | Cellular (LTE-M), Bluetooth β phone β cloud | Verizon ThingSpace, AWS IoT Core, Azure IoT Hub |
| AI/ML layer | Anomaly detection, deterioration prediction, alert prioritisation | Current Health AI, Biofourmis, Cardiogram, custom ML |
| Clinical workflow | Escalation to nursing team, EHR integration, care plan adjustment | Epic MyChart, Salesforce Health Cloud, custom portals |
| Patient engagement | Patient app, symptom questionnaires, medication reminders | Twilio messaging, custom PWA, Dario Health platform |
25%
Reduction in 30-day hospital readmissions for heart failure patients enrolled in AI-powered RPM programmes vs standard discharge β the primary ROI driver for payers and risk-bearing providers
48h
Median advance warning time before clinical deterioration identified by current RPM AI systems β early enough for outpatient intervention in most cases, preventing emergency admission
CPT 99453
US RPM reimbursement code β CMS reimburses RPM programme setup ($19) and monthly monitoring ($57/month) for qualifying chronic disease patients, creating the reimbursement model that makes RPM financially sustainable
β€οΈ
Cardiac RPM
Continuous ECG patches (Zio XT, BioTelemetry) for post-discharge arrhythmia monitoring; wearable blood pressure (Withings, Omron) for hypertension management; AI analysis detects AFib, hypertensive crisis, and heart failure decompensation. Current Health's AI platform integrates multi-sensor cardiac RPM with Epic EHR for seamless clinical workflow. FDA-cleared for cardiac monitoring indications. The highest-volume RPM use case in US health systems.
π©Ί
Diabetes Management
Continuous glucose monitors (Dexcom G7, Libre 3) provide real-time glucose data to AI that predicts hypoglycaemic episodes 30 minutes before they occur β alerting both the patient and the care team. Integrated with insulin pump data for closed-loop management. Dario Health and Omada's enterprise diabetes programmes combine CGM, AI coaching, and RPM for employer-sponsored chronic disease management with measured HbA1c reduction outcomes.
π«
COPD and Respiratory Monitoring
SpO2 + respiratory rate + activity monitoring for COPD and post-COVID patients at risk of exacerbation. AI detects the 3β5 day physiological signal that precedes COPD exacerbations β enabling outpatient antibiotic/steroid intervention before hospitalisation. Biofourmis and VitalConnect provide FDA-cleared patch sensors with AI analysis for respiratory RPM. COPD readmission reduction is one of the highest-ROI RPM use cases for hospitals under value-based care arrangements.
π
Post-Surgical Recovery
Activity, vital sign, and wound sensor monitoring for total joint replacement, bariatric, and cardiac surgery patients in the 30β90 days post-discharge. AI identifies deviations from expected recovery trajectories β reduced activity, abnormal temperature, irregular vitals β and escalates to the surgical team for intervention. Reduces post-surgical complication-related readmissions by 30β40% in pilot deployments. Integrates with Epic Care Everywhere for surgical team review without leaving their existing workflow.
β FDA, HIPAA, and Clinical Governance Requirements
AI-powered RPM systems that influence clinical decision-making require FDA clearance (Class II, 510(k) pathway for most RPM AI functions). All PHI transmitted from wearables through the RPM platform requires HIPAA-compliant infrastructure with BAA. Clinical governance: every RPM alert must have a defined clinical escalation pathway β who receives the alert, what are they expected to do, and what is the response time expectation. Without clear escalation protocols, RPM alert fatigue creates liability rather than value.